Toll-like receptor (TLR)-9 genetics and function in sarcoidosis

被引:29
作者
Veltkamp, M. [1 ]
van Moorsel, C. H. M. [1 ,3 ]
Rijkers, G. T. [2 ]
Ruven, H. J. T. [3 ]
van den Bosch, J. M. M. [1 ,4 ]
Grutters, J. C. [1 ,4 ]
机构
[1] St Antonius Hosp, Dept Pulmonol, Ctr Interstitial Lung Dis, NL-3430 EM Nieuwegein, Netherlands
[2] St Antonius Hosp, Dept Med Microbiol & Immunol, NL-3430 EM Nieuwegein, Netherlands
[3] St Antonius Hosp, Dept Clin Chem, NL-3430 EM Nieuwegein, Netherlands
[4] Univ Utrecht, Med Ctr, Div Heart & Lungs, Utrecht, Netherlands
关键词
cytokine production; polymorphisms; sarcoidosis; Toll-like receptor-9; BLOOD MONONUCLEAR-CELLS; MYCOBACTERIAL CATALASE-PEROXIDASE; INTERFERON-GAMMA PRODUCTION; GREEK PATIENTS; POLYMORPHISMS; DNA; TLR9; EXPRESSION; PROPIONIBACTERIAL; ASSOCIATION;
D O I
10.1111/j.1365-2249.2010.04205.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Sarcoidosis is a systemic disorder characterized by the formation of non-caseating granulomas in variable organs. Toll-like receptor (TLR)-9 is important in the innate immune response against both Mycobacterium tuberculosis and Propionibacterium acnes, candidate causative agents in sarcoidosis. The aim of our study was to investigate possible genetic and functional differences in TLR-9 between patients and controls. TLR-9 single nucleotide polymorphisms were genotyped in 533 patients and divided into a study cohort and validation cohort and 185 healthy controls. Furthermore, part of the promotor as well as the entire coding region of the TLR-9 gene were sequenced in 20 patients in order to detect new mutations. No genetic differences were found between patients and controls. In order to test TLR-9 function, peripheral blood mononuclear cells (PBMCs) of 12 healthy controls and 12 sarcoidosis patients were stimulated with a TLR-9 agonist and the induction of interleukin (IL)-6, interferon (IFN)-gamma and IL-23 was measured. Sarcoidosis patients produce significantly less IFN-gamma upon stimulation with different stimuli. Regarding IL-23 production, a significant difference between patients and controls was found only after stimulation with the TLR-9 agonist. In conclusion, we did not find genetic differences in the TLR-9 gene between sarcoidosis patients and controls. Sarcoidosis patients produce less IFN-gamma regardless of the stimulating agent, probably reflecting the anergic state often seen in their peripheral blood T lymphocytes. The differences in TLR-9-induced IL-23 production could indicate that functional defects in the TLR-9 pathway of sarcoidosis patients play a role in disease susceptibility or evolution.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 36 条
  • [1] TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
    Bafica, A
    Scanga, CA
    Feng, CG
    Leifer, C
    Cheever, A
    Sher, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) : 1715 - 1724
  • [2] INHIBITION OF INTERFERON GAMMA PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR LEUKOCYTES OF PATIENTS WITH SARCOIDOSIS - PATHOGENIC IMPLICATIONS
    BERTRAN, G
    ARZT, E
    RESNIK, E
    MOSCA, C
    NAHMOD, V
    [J]. CHEST, 1992, 101 (04) : 996 - 999
  • [3] Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
    Bunce, M
    ONeill, CM
    Barnardo, MCNM
    Krausa, P
    Browning, MJ
    Morris, PJ
    Welsh, KI
    [J]. TISSUE ANTIGENS, 1995, 46 (05): : 355 - 367
  • [4] T Cell Responses to Mycobacterial Catalase-Peroxidase Profile a Pathogenic Antigen in Systemic Sarcoidosis
    Chen, Edward S.
    Wahlstrom, Jan
    Song, Zhimin
    Willett, Matthew H.
    Wiken, Maria
    Yung, Rex C.
    West, Erin E.
    McDyer, John F.
    Zhang, Ying
    Eklund, Anders
    Grunewald, Johan
    Moller, David R.
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (12) : 8784 - 8796
  • [5] IMMUNOLOGICAL ABNORMALITIES IN SARCOIDOSIS
    DANIELE, RP
    DAUBER, JH
    ROSSMAN, MD
    [J]. ANNALS OF INTERNAL MEDICINE, 1980, 92 (03) : 406 - 416
  • [6] de Jager Wilco, 2009, V514, P119, DOI 10.1007/978-1-60327-527-9_9
  • [7] DE JW, 2006, METHODS, V38, P294
  • [8] Serum anti-mycobacteria heat shock proteins antibodies in sarcoidosis and tuberculosis
    Dubaniewicz, A
    Kämpfer, S
    Singh, M
    [J]. TUBERCULOSIS, 2006, 86 (01) : 60 - 67
  • [9] Ebe Y, 2000, SARCOIDOSIS VASC DIF, V17, P256
  • [10] Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis
    Eishi, Y
    Suga, M
    Ishige, I
    Kobayashi, D
    Yamada, T
    Takemura, T
    Takizawa, T
    Koike, M
    Kudoh, S
    Costabel, U
    Guzman, J
    Rizzato, G
    Gambacorta, M
    du Bois, R
    Nicholson, AG
    Sharma, OP
    Ando, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (01) : 198 - 204